AIM
AGIO icon

Allen Investment Management’s Agios Pharmaceuticals AGIO Stock Holding History

Allen Investment Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,781
Closed -$638K – 200
2025
Q1 		$638K Hold
21,781
– – 0.01% 150
2024
Q4 		$716K Hold
21,781
– – 0.01% 148
2024
Q3 		$968K Hold
21,781
– – 0.01% 146
2024
Q2 		$939K Sell
21,781
-21,790
-50% -$786K 0.01% 145
2024
Q1 		$1.27M Buy
43,571
+7,405
+20% +$198K 0.02% 124
2023
Q4 		$805K Buy
+36,166
New +$810K 0.01% 142

Other funds holding AGIO

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allen Investment Management's AGIO Position: Q2 2025 in Review

Allen Investment Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2025, closing a stake of 21,781 shares — an estimated $638K sold.

Allen Investment Management first reported a position in AGIO in Q4 2023 and held it in 6 quarters. The position peaked at $1.27M in Q1 2024. 215 funds tracked by Wall St. Rank hold AGIO as of Q2 2025.

  • Allen Investment Management reported no remaining Agios Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Allen Investment Management sold 21,781 Agios Pharmaceuticals shares in Q2 2025, an estimated $638K.
  • Allen Investment Management first reported a position in Agios Pharmaceuticals in Q4 2023 and held it in 6 quarters.
  • Allen Investment Management's Agios Pharmaceuticals position peaked at $1.27M in Q1 2024.
  • 215 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2025.

Based on Allen Investment Management's 13F filing for Q2 2025, filed 7 Aug 2025.